Sacubitril-valsartan in patients with NT-proBNP levels outrange of PARADIGM-HF trial inclusion criteria

被引：0
|
作者：
Mario Galvan Ruiz, M. [1 ]
Fernandez De Sanmamed Giron, M. [1 ]
Singh, M. [1 ]
Groba Marco, M. V. [1 ]
Davila Ramos, M. [2 ]
Lopez Perez, M. [1 ]
Hernandez Meneses, B. [1 ]
Godoy Camacho, C. [1 ]
Martin Lorenzo, P. [1 ]
Cardenes Leon, A. [1 ]
Bujanda Morun, P. [1 ]
Perez Nogales, E. D. [3 ]
Medina Gil, J. M. [3 ]
Caballero Dorta, E. [1 ]
Garcia Quintana, A. [1 ]
机构：
[1] Univ Hosp Dr Negrin, Las Palmas Gran Canaria, Spain
[2] Univ Hosp Nuestra Seora Candelaria, Santa Cruz De Tenerife, Spain
[3] Univ Hosp Insular Gran Canaria, Las Palmas Gran Canaria, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P587
引用
收藏
页码：112 / 113
页数：2
相关论文
共 50 条
  • [1] Prognostic value of NT-ProBNP/BNP ratio in patients with heart failure and reduced ejection fraction using sacubitril-valsartan: systematic review and post hoc analysis of PARADIGM-HF Trial
    Eduardo Pitthan, E.
    Hirakata, V. N.
    Barbisan, J. N.
    Rodrigues, C. G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 245 - 245
  • [2] Safety of sacubitril/valsartan in patients receiving statins in the PARADIGM-HF trial
    Streefkerk, H.
    Anand, D.
    Zhou, W.
    Balas, B.
    Schwende, H.
    Shi, V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 411 - 412
  • [3] WILL NT-PROBNP/BNP RATIO DISCRIMINATE RESPONDER AND NO RESPONDER AMONG PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION UNDERGOING TREATMENT WITH SACUBITRIL-VALSARTAN? SYSTEMATIC REVIEW AND POST HOC ANALYSIS OF PARADIGM-HF TRIAL
    Pitthan, Eduardo
    Hirakata, Vania
    Barbisan, Juarez
    Rodrigues, Clarissa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 772 - 772
  • [4] Sacubitril/valsartan in HFrEF patients with low NT-proBNP levels: any benefit?
    Pereira, S. Sara Couto
    Agostinho, J. R.
    Rodrigues, T.
    Antonio, P. Silverio
    Morais, P. Simoes
    Cunha, N.
    Da Silva, P. Alves
    Brito, J.
    Silva, B.
    Santos, R.
    Rigueira, J.
    Nunes-Ferreira, A.
    Pinto, F. J.
    Brito, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 133 - 133
  • [5] Outcomes and effects of sacubitril/valsartan according to NT-proBNP level in patients with heart failure: a patient-level pooled analysis of the PARADIGM-HF and PARAGON-HF trials
    Kondo, T.
    Jhund, P. S.
    Anand, I. S.
    Desai, A. S.
    Lam, C. S. P.
    Maggioni, A. P.
    Martinez, F. A.
    Redfield, M. M.
    Rouleau, J. L.
    Van Veldhuisen, D. J.
    Zannad, F.
    Zile, M. R.
    Packer, M.
    Solomon, S. D.
    Mcmurray, J. J., V
    EUROPEAN HEART JOURNAL, 2024, 45
  • [6] Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation The PARADIGM-HF Trial
    Solomon, Scott D.
    Claggett, Brian
    Packer, Milton
    Desai, Akshay
    Zile, Michael R.
    Swedberg, Karl
    Rouleau, Jean
    Shi, Victor
    Lefkowitz, Martin
    McMurray, John J. V.
    JACC-HEART FAILURE, 2016, 4 (10) : 816 - 822
  • [7] Role of BNP vs NT-proBNP Testing in the Age of New Drug Therapies: Sacubitril-Valsartan
    Apple, Fred S.
    Daniels, Lori B.
    Januzzi, James
    Omland, Torbjorn
    Ordonez-Llanos, Jordi
    Jaffe, Allan
    CLINICAL CHEMISTRY, 2019, 65 (09) : 1076 - 1083
  • [8] Prognostic implications of NYHA class and NT-proBNP levels in mild heart failure: a PARADIGM-HF analysis
    Rohde, L. E.
    Zimerman, A.
    Claggett, B.
    Packer, M.
    Desai, A. S.
    Zile, M.
    Rouleau, J.
    Swedberg, K.
    Lefkowitz, M.
    Shi, V
    McMurray, J.
    Vaduganathan, M.
    Solomon, S. D.
    EUROPEAN HEART JOURNAL, 2022, 43 : 891 - 891
  • [9] Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF
    Jhund, Pardeep S.
    Fu, Michael
    Bayram, Edmundo
    Chen, Chen-Huan
    Negrusz-Kawecka, Marta
    Rosenthal, Arvo
    Desai, Akshay S.
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Rouleau, Jean L.
    Shi, Victor C.
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael R.
    McMurray, John J. V.
    Packer, Milton
    EUROPEAN HEART JOURNAL, 2015, 36 (38) : 2576 - 2584
  • [10] Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial
    Vardeny, Orly
    Claggett, Brian
    Kachadourian, Jessica
    Desai, Akshay S.
    Packer, Milton
    Rouleau, Jean
    Zile, Michael R.
    Swedberg, Karl
    Lefkowitz, Martin
    Shi, Victor
    McMurray, John J. V.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (03) : 337 - 341
12345